Posts by Karen Carroll
The U.S. Supreme Court’s 2013 ruling in Association for Molecular Pathology v. Myriad Genetics changed the landscape of what is considered patentable material in the context …
a partner in Parker Poe’s Life Sciences Industry Team. Based in Atlanta, her practice focuses on pharmaceutical and biotechnology-related patent litigation and counseling. Prior to her legal career, Karen worked for more than 10 years in the biopharmaceutical industry, first as a research scientist at the Department of Neuropathology at Johns Hopkins University and Codon Pharmaceuticals, and then as a patent agent at Human Genome Sciences Inc.
For more information or to contact Karen, please visit her Firm Profile Page.